Skip to main content

10 publications

Name Date Type Actions

Rapport financier semestriel 2023 (french)

Rapport financier semestriel 2023 (french)

12/09/2023 Half Year Report

2023 Half-Year Results

Contents
1.H1 2023 Highlights
2.H1 2023 Consolidatedfinancialstatements
3.Strategyand outlook

07/09/2023 Half Year Report

Rapport financier semestriel 2022 (french)

Rapport financier semestriel 2022 (french)

26/06/2023 Half Year Report

[VIDEO] Présentation des résultats annuels 2022 -French

Présentation analystes & investisseurs - 23 Mars 2023

23/03/2023 Annual Report

ANNUAL RESULTS 2022 (slideshow)

01.2022 Highlights
02.2022 Consolidated financial statements
03.Strategy and outlook

23/03/2023 Annual Report

First half Results

2013 Half year results

09/09/2013 Half Year Report

Half year financial report 2013

2013 Half year Financial Report

30/08/2013 Half Year Report

Vétoquinol : 80 years striving for animal health worldwide

Founded in 1933, Vétoquinol is now a leading global animal health company.
The number 10 global animal health company and the third
largest in France, the Vétoquinol Group combines sustainability,
growth and independence in an increasingly competitive world
market.
Committed to the protection and well-being of both animals
and people, Vétoquinol creates, develops and sells veterinary
drugs and non-medical products all over the world.
The company is widely reputed for its expertise in the fields of infectious diseases, pain and inflammation in livestock (cattle and pigs) and pets (dogs and cats).
For over 80 years, Vétoquinol's pursuit of growth has been underpinned by strong values of team spirit, performance and the sharing of corporate culture and know-how with customers, vets, breeders, partners and employees alike.

17/05/2013 Annual Report

Financial statements 2012

1.1CONSOLIDATED FINANCIAL STATEMENTS p.4

30/04/2013 Annual Report

2012 ANNUAL RESULTS

SFAF Meeting March 27, 2013

28/03/2013 Annual Report